168 related articles for article (PubMed ID: 38488881)
21. Stereotactic body radiotherapy improves the survival of patients with oligometastatic non-small cell lung cancer.
Ouyang W; Yu J; Nuerjiang S; Li Z; Wang D; Wang X; Zhang J; Xie C
Cancer Med; 2019 Aug; 8(10):4605-4614. PubMed ID: 31245933
[TBL] [Abstract][Full Text] [Related]
22. Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastases.
Sogono P; Bressel M; David S; Shaw M; Chander S; Chu J; Plumridge N; Byrne K; Hardcastle N; Kron T; Wheeler G; Hanna GG; MacManus M; Ball D; Siva S
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):756-763. PubMed ID: 33069796
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
König L; Häfner MF; Katayama S; Koerber SA; Tonndorf-Martini E; Bernhardt D; von Nettelbladt B; Weykamp F; Hoegen P; Klüter S; Susko MS; Debus J; Hörner-Rieber J
Radiat Oncol; 2020 Feb; 15(1):30. PubMed ID: 32019553
[TBL] [Abstract][Full Text] [Related]
24. Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy.
Nicosia L; Cuccia F; Mazzola R; Ricchetti F; Figlia V; Giaj-Levra N; Rigo M; Tomasini D; Pasinetti N; Corradini S; Ruggieri R; Alongi F
Strahlenther Onkol; 2020 Sep; 196(9):813-820. PubMed ID: 32399637
[TBL] [Abstract][Full Text] [Related]
25. Overall and chemotherapy-free survival following stereotactic body radiation therapy for abdominopelvic oligometastases.
Shahi J; Peng J; Donovan E; Vansantvoort J; Wong R; Tsakiridis T; Quan K; Parpia S; Swaminath A
J Med Imaging Radiat Oncol; 2020 Aug; 64(4):563-569. PubMed ID: 32497405
[TBL] [Abstract][Full Text] [Related]
26. Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases.
Kalinauskaite GG; Tinhofer II; Kufeld MM; Kluge AA; Grün AA; Budach VV; Senger CC; Stromberger CC
BMC Cancer; 2020 May; 20(1):404. PubMed ID: 32393261
[TBL] [Abstract][Full Text] [Related]
27. Uncovering the armpit of SBRT: An institutional experience with stereotactic radiation of axillary metastases.
Mutsaers A; Li GJ; Fernandes JS; Ali S; Barnes EA; Chen H; Czarnota GJ; Karam I; Moore-Palhares D; Poon I; Soliman H; Vesprini D; Cheung P; Louie AV
Clin Transl Radiat Oncol; 2024 Mar; 45():100730. PubMed ID: 38317679
[TBL] [Abstract][Full Text] [Related]
28. Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience.
Ricco A; Davis J; Rate W; Yang J; Perry D; Pablo J; D'Ambrosio D; Sharma S; Sundararaman S; Kolker J; Creach KM; Lanciano R
Radiat Oncol; 2017 Feb; 12(1):35. PubMed ID: 28143558
[TBL] [Abstract][Full Text] [Related]
29. Outcomes for oligometastatic head and neck cancer treated with stereotactic body radiotherapy: Results from an international multi-institutional consortium.
Id Said B; Mutsaers A; Chen H; Husain ZA; Biswas T; Dagan R; Erler D; Foote M; Louie AV; Redmond K; Ricardi U; Sahgal A; Poon I
Head Neck; 2023 Oct; 45(10):2627-2637. PubMed ID: 37602655
[TBL] [Abstract][Full Text] [Related]
30. Patient and Treatment Factors Associated With Improved Local Control and Survival in Oligometastatic Bone Disease: Results From a Large Single-Institution Experience Using Stereotactic Body Radiation Therapy.
Thomas MC; Chen YH; Fite E; Pangilinan A; Bubelo K; Spektor A; Balboni TA; Huynh MA
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(4):747-761. PubMed ID: 35840113
[TBL] [Abstract][Full Text] [Related]
31. Stereotactic Body Radiotherapy for Lymph-Nodal Oligometastatic Prostate Cancer: A Multicenter Retrospective Experience.
Cuccia F; Tamburo M; Piras A; Mortellaro G; Iudica A; Daidone A; Federico M; Zagardo V; Ferini G; Marletta F; Spatola C; Fazio I; Filosto S; Pergolizzi S; Ferrera G
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629732
[No Abstract] [Full Text] [Related]
32. Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy.
Gutkin PM; Gore E; Charlson J; Neilson JC; Johnstone C; King DM; Hackbarth DA; Wooldridge A; Mannem R; Bedi M
Radiat Oncol; 2023 Mar; 18(1):42. PubMed ID: 36859309
[TBL] [Abstract][Full Text] [Related]
33. Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer.
Xu B; Zhao X; Chen D; Zhao W; Wang X; Ding C; Yuan Z; Zhang H
BMC Cancer; 2023 Jan; 23(1):73. PubMed ID: 36681809
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic Body Radiotherapy for Extracranial Oligometastatic Disease from Head and Neck Primary Cancers: A Systematic Review and Meta-Analysis.
Mutsaers A; Akingbade A; Louie AV; Id Said B; Zhang L; Poon I; Smoragiewicz M; Eskander A; Karam I
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473213
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes and efficacy of stereotactic body radiation therapy in children, adolescents, and young adults with metastatic solid tumors.
Baliga S; Matsui J; Klamer B; Cetnar A; Ewing A; Cadieux C; Gupta A; Setty BA; Roberts RD; Olshefski RS; Cripe TP; Scharschmidt TJ; Aldrink J; Mardis E; Yeager ND; Palmer JD
Br J Radiol; 2022 May; 95(1133):20211088. PubMed ID: 35073182
[TBL] [Abstract][Full Text] [Related]
36. [Stereotactic body radiation therapy for patients with lung and liver oligometastases from colorectal cancer: a phase Ⅱ trial].
Lei JQ; Liu WY; Tang Y; Tang Y; Li N; Ren H; Yihebali C; Sun YK; Zhang W; Bi XY; Zhao JJ; Fang H; Lu NN; Zhou AP; Wang SL; Song YW; Liu YP; Chen B; Qi SN; Cai JQ; Li YX; Jin J
Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):282-290. PubMed ID: 35316879
[No Abstract] [Full Text] [Related]
37. Is stereotactic body radiotherapy an effective treatment in metastatic lung cancer with oligoprogressive disease?
Aquilano M; Loi M; Visani L; Livi L; Nuyttens JJ
Acta Oncol; 2023 Mar; 62(3):298-304. PubMed ID: 36905644
[TBL] [Abstract][Full Text] [Related]
38. A Large, Multicenter, Retrospective Study on Efficacy and Safety of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups.
Macchia G; Lazzari R; Colombo N; Laliscia C; Capelli G; D'Agostino GR; Deodato F; Maranzano E; Ippolito E; Ronchi S; Paiar F; Scorsetti M; Cilla S; Ingargiola R; Huscher A; Cerrotta AM; Fodor A; Vicenzi L; Russo D; Borghesi S; Perrucci E; Pignata S; Aristei C; Morganti AG; Scambia G; Valentini V; Jereczek-Fossa BA; Ferrandina G
Oncologist; 2020 Feb; 25(2):e311-e320. PubMed ID: 32043791
[TBL] [Abstract][Full Text] [Related]
39. Impact of stereotactic body radiotherapy (SBRT) in oligoprogressive metastatic disease.
Ramadan S; Quan K; Schnarr K; Juergens RA; Hotte SJ; Mukherjee SD; Kapoor A; Meyers BM; Swaminath A
Acta Oncol; 2022 Jun; 61(6):705-713. PubMed ID: 35435129
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic Body Radiotherapy of Lymph Node Oligometastases.
Burkoň P; Oberreiterová S; Kazda T; Slávik M; Bobek L; Komínek L; Procházka T; Vrzal M; Šlampa P
Klin Onkol; 2020; 33(2):114-122. PubMed ID: 32303132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]